$1.24
-0.18-12.68%
마지막 업데이트: Oct 16, 7:49 PM
$1.26
-0.16-11.27%
Benzinga
Benzinga
Benzinga
일요일, 10월 18
Benzinga
© 2026 Benzinga | All Rights Reserved
XORTX Therapeutics (XRTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | $-1.60 | $-1.60 |
| Actual | $-1.05 | $-0.58 | $-0.45 | $-0.65 |
| Surprise | — | — | +71.9% | +59.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q4 | Feb 27, 2026 | $-0.45 | $-1.60 | 71.9 % |
| Q3 | Nov 17, 2025 | $-0.65 | $-1.60 | 59.4 % |
| Q4 | May 10, 2024 | $6.80 | $-2.20 | 409.1 % |
| Q3 | Nov 16, 2023 | $-3.35 | $-0.95 | -252.6 % |